• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

暴露于胆汁和胃液会影响囊性纤维化患者的气液消化微生物组。

Exposure to bile and gastric juice can impact the aerodigestive microbiome in people with cystic fibrosis.

机构信息

Basic Medical Science Department, School of Medicine, The Hashemite University, Zarqa, Jordan.

Department of Microbiology, Freeman Hospital, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE7 7DN, UK.

出版信息

Sci Rep. 2022 Jun 30;12(1):11114. doi: 10.1038/s41598-022-15375-4.

DOI:10.1038/s41598-022-15375-4
PMID:35773410
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9247099/
Abstract

Studies of microbiota reveal inter-relationships between the microbiomes of the gut and lungs. This relationship may influence the progression of lung disease, particularly in patients with cystic fibrosis (CF), who often experience extraoesophageal reflux (EOR). Despite identifying this relationship, it is not well characterised. Our hypothesis is that the gastric and lung microbiomes in CF are related, with the potential for aerodigestive pathophysiology. We evaluated gastric and sputum bacterial communities by culture and 16S rRNA gene sequencing in 13 CF patients. Impacts of varying levels of bile acids, pepsin and pH on patient isolates of Pseudomonas aeruginosa (Pa) were evaluated. Clonally related strains of Pa and NTM were identified in gastric and sputum samples from patients with symptoms of EOR. Bacterial diversity was more pronounced in sputa compared to gastric juice. Gastric and lung bile and pepsin levels were associated with Pa biofilm formation. Analysis of the aerodigestive microbiomes of CF patients with negative sputa indicates that the gut can be a reservoir of Pa and NTM. This combined with the CF patient's symptoms of reflux and potential aspiration, highlights the possibility of communication between microorganisms of the gut and the lungs. This phenomenon merits further research.

摘要

研究微生物组揭示了肠道和肺部微生物组之间的相互关系。这种关系可能会影响肺部疾病的进展,特别是在经常经历食管外反流(EOR)的囊性纤维化(CF)患者中。尽管已经确定了这种关系,但它的特征尚未得到很好的描述。我们的假设是 CF 患者的胃和肺部微生物组是相关的,具有潜在的气液生理病理学。我们通过培养和 16S rRNA 基因测序评估了 13 名 CF 患者的胃和痰液细菌群落。评估了不同水平的胆汁酸、胃蛋白酶和 pH 值对铜绿假单胞菌(Pa)患者分离株的影响。在有 EOR 症状的患者的胃和痰液样本中,鉴定出了与 Pa 和非结核分枝杆菌(NTM)相关的克隆相关菌株。与胃液相比,痰液中的细菌多样性更为明显。胃和肺部的胆汁和胃蛋白酶水平与 Pa 生物膜形成有关。对痰液阴性的 CF 患者的气液微生物组进行分析表明,肠道可以成为 Pa 和 NTM 的储库。再加上 CF 患者的反流和潜在的吸入症状,突显了肠道和肺部微生物之间进行交流的可能性。这种现象值得进一步研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/1e58847dd4d9/41598_2022_15375_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/c9bee2640098/41598_2022_15375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/31172779b944/41598_2022_15375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/7ad2bced19d7/41598_2022_15375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/1e58847dd4d9/41598_2022_15375_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/c9bee2640098/41598_2022_15375_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/31172779b944/41598_2022_15375_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/7ad2bced19d7/41598_2022_15375_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3eaf/9247099/1e58847dd4d9/41598_2022_15375_Fig4_HTML.jpg

相似文献

1
Exposure to bile and gastric juice can impact the aerodigestive microbiome in people with cystic fibrosis.暴露于胆汁和胃液会影响囊性纤维化患者的气液消化微生物组。
Sci Rep. 2022 Jun 30;12(1):11114. doi: 10.1038/s41598-022-15375-4.
2
Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients.囊性纤维化患者痰液和胃液抽吸物的微生物学特征
Sci Rep. 2016 Jun 1;6:26985. doi: 10.1038/srep26985.
3
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission.成人新冠病毒感染期间上呼吸道和肠道细菌微生物群评估:气消化道传播的可能性
Sci Rep. 2025 Jan 13;15(1):1811. doi: 10.1038/s41598-025-85806-5.
4
Microbial, host and xenobiotic diversity in the cystic fibrosis sputum metabolome.囊性纤维化痰液代谢组中的微生物、宿主和外源性物质多样性。
ISME J. 2016 Jun;10(6):1483-98. doi: 10.1038/ismej.2015.207. Epub 2015 Dec 1.
5
Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients.用于检测囊性纤维化患者痰液样本中细菌病原体的传统方法与分子方法的比较。
FEMS Immunol Med Microbiol. 2000 Jan;27(1):51-7. doi: 10.1111/j.1574-695X.2000.tb01411.x.
6
Different next generation sequencing platforms produce different microbial profiles and diversity in cystic fibrosis sputum.不同的下一代测序平台在囊性纤维化痰液中产生不同的微生物谱和多样性。
J Microbiol Methods. 2016 Nov;130:95-99. doi: 10.1016/j.mimet.2016.09.002. Epub 2016 Sep 5.
7
Aerodigestive sampling reveals altered microbial exchange between lung, oropharyngeal, and gastric microbiomes in children with impaired swallow function.气液消化采样揭示了吞咽功能受损的儿童的肺部、口咽和胃微生物组之间微生物交换的改变。
PLoS One. 2019 May 20;14(5):e0216453. doi: 10.1371/journal.pone.0216453. eCollection 2019.
8
Neutrophilic proteolysis in the cystic fibrosis lung correlates with a pathogenic microbiome.中性粒细胞蛋白酶在囊性纤维化肺中的作用与致病微生物组有关。
Microbiome. 2019 Feb 13;7(1):23. doi: 10.1186/s40168-019-0636-3.
9
Reemergence of Lower-Airway Microbiota in Lung Transplant Patients with Cystic Fibrosis.囊性纤维化肺移植患者下呼吸道微生物群的再度出现
Ann Am Thorac Soc. 2016 Dec;13(12):2132-2142. doi: 10.1513/AnnalsATS.201606-431OC.
10
Lung and Gut Microbiota Changes Associated with Infection in Mouse Models of Cystic Fibrosis.肺部和肠道微生物组变化与囊性纤维化小鼠模型中的感染相关。
Int J Mol Sci. 2021 Nov 10;22(22):12169. doi: 10.3390/ijms222212169.

引用本文的文献

1
Assessment of upper respiratory and gut bacterial microbiomes during COVID-19 infection in adults: potential aerodigestive transmission.成人新冠病毒感染期间上呼吸道和肠道细菌微生物群评估:气消化道传播的可能性
Sci Rep. 2025 Jan 13;15(1):1811. doi: 10.1038/s41598-025-85806-5.
2
Critical appraisal of how COVID-19 infection and imposed lockdowns have impacted gastroesophageal reflux: A review.新冠病毒感染和强制封锁对胃食管反流影响的批判性评价:综述。
Medicine (Baltimore). 2024 May 10;103(19):e38074. doi: 10.1097/MD.0000000000038074.
3
Bile effects on the pathogenesis in cystic fibrosis patients with gastroesophageal reflux.

本文引用的文献

1
Current therapies for gastro-oesophageal reflux in the setting of chronic lung disease: state of the art review.慢性肺病背景下胃食管反流的当前治疗方法:最新综述
ERJ Open Res. 2020 Nov 10;6(4). doi: 10.1183/23120541.00190-2019. eCollection 2020 Oct.
2
The lung and gut microbiome: what has to be taken into consideration for cystic fibrosis?肺和肠道微生物组:囊性纤维化需要考虑什么?
J Cyst Fibros. 2019 Jan;18(1):13-21. doi: 10.1016/j.jcf.2018.11.003. Epub 2018 Nov 25.
3
Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review.
胆汁对患有胃食管反流的囊性纤维化患者发病机制的影响。
Heliyon. 2023 Nov 10;9(11):e22111. doi: 10.1016/j.heliyon.2023.e22111. eCollection 2023 Nov.
4
The Potential Role of Gastric Microbiology in Respiratory Disease.胃微生物群在呼吸系统疾病中的潜在作用
Am J Respir Crit Care Med. 2023 Sep 1;208(5):630-631. doi: 10.1164/rccm.202303-0366LE.
5
Efflux, Signaling and Warfare in a Polymicrobial World.多微生物世界中的外排、信号传导与竞争
Antibiotics (Basel). 2023 Apr 8;12(4):731. doi: 10.3390/antibiotics12040731.
囊性纤维化治疗决策证据中的差距:系统评价。
Thorax. 2019 Mar;74(3):229-236. doi: 10.1136/thoraxjnl-2017-210858. Epub 2018 Oct 9.
4
Risk factors for lung disease progression in children with cystic fibrosis.囊性纤维化患儿肺部疾病进展的风险因素。
Eur Respir J. 2018 Oct 4;52(4). doi: 10.1183/13993003.01492-2018. Print 2018 Oct.
5
Critical Assessment of Methods to Quantify Biofilm Growth and Evaluate Antibiofilm Activity of Host Defence Peptides.定量评估生物膜生长和评估宿主防御肽抗生物膜活性的方法的批判性评估。
Biomolecules. 2018 May 21;8(2):29. doi: 10.3390/biom8020029.
6
Risk factors for lung disease progression in children with cystic fibrosis.囊性纤维化患儿肺部疾病进展的危险因素。
Eur Respir J. 2018 Jun 7;51(6). doi: 10.1183/13993003.02509-2017. Print 2018 Jun.
7
Nontuberculous mycobacteria in gastrostomy fed patients with cystic fibrosis.胃造口喂养囊性纤维化患者中的非结核分枝杆菌。
Sci Rep. 2017 Apr 24;7:46546. doi: 10.1038/srep46546.
8
Strategies for combating bacterial biofilms: A focus on anti-biofilm agents and their mechanisms of action.对抗细菌生物膜的策略:聚焦于抗生物膜剂及其作用机制。
Virulence. 2018 Jan 1;9(1):522-554. doi: 10.1080/21505594.2017.1313372.
9
Ivacaftor and symptoms of extra-oesophageal reflux in patients with cystic fibrosis and G551D mutation.依伐卡托与囊性纤维化G551D突变患者的食管外反流症状
J Cyst Fibros. 2017 Jan;16(1):124-131. doi: 10.1016/j.jcf.2016.07.004. Epub 2016 Jul 27.
10
Bile signalling promotes chronic respiratory infections and antibiotic tolerance.胆汁信号促进慢性呼吸道感染和抗生素耐药性。
Sci Rep. 2016 Jul 19;6:29768. doi: 10.1038/srep29768.